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Peribulbar anesthesiaAbstract Purpose: Purpose was to evaluate the quality of the block and the duration of postop-
erative analgesia when ultra-low-dose of naloxone added to fentanyl and lidocaine for peribulbar
anesthesia.
Methods: Sixty adult patients of both sexes, ASA I and II scheduled for open globe cataract
surgery in the Ophthalmology Department Tanta University Hospital were included in this
randomized prospective clinical trial.
The patients were randomized into 2 groups (30 patients each). Group I: patients received 50 lg
fentanyl and lidocaine 2% with hyaluronidase 15 IU/ml. Group II: patients received 100 gg
naloxone, 50 lg fentanyl and lidocaine 2% with hyaluronidase 15 IU/ml.
Total akinesia was scored every 2 min till the best akinesia score. Onset, best akinesia score, total
injected volume, number of patients needed supplemental injection, time of ﬁrst request for
analgesia and, any complication were recorded. Pain was assessed during and after surgery at 30,
60, 90 min, 2, 3, 4, 6 and 8 h postoperatively, using Visual Analogue Score; 0 = no pain, to
10 = maximum pain.
Results: The time to ﬁrst rescue analgesic was signiﬁcantly longer in group II (7.73 ± 0.98) than
group I (4.30 ± 0.47). The IOP was increased signiﬁcantly at 2 min post-injection then, it became
insigniﬁcant at 10 min postinjection compared to the preinjection values in both groups. There were
few minor complications with no signiﬁcant difference between groups.
Conclusion: Addition of ultra-low-dose naloxone to fentanyl and lidocaine for peribulbar anesthe-
sia prolongs the duration of postoperative analgesia without increasing the adverse effects.
ª 2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists.1. Introduction
When fentanyl was used as adjuvant to local anesthetic, it
improved the quality of block and prolonged the duration of
postoperative analgesia, without increasing the side effects. It
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also used as adjuvant to local anesthetic for peripheral nerve
blocks; e.g. axillary brachial plexus block [3,4], cervical plexus
block [5], Intravenous regional anesthesia [6], infra-orbital
nerve block [7], and in intra-articular injection after knee
arthroplasty [8]. It has been reported that opioid receptors
are expressed by central and peripheral neurons especially
within injured tissues and can attenuate the excitability of pri-
mary afferent neurons and lead to anti-nociceptive effects [9].
Peribulbar block is easier, safer, and less painful but, has a
higher failure rate, and a longer onset time compared with ret-
robulbar block, unless the onset is accelerated with the use of
adjuvants [10,11]. Fentanyl as adjuvant to lidocaine is safe and
effective in improving postoperative analgesia of peribulbar
anesthesia [12–14]. However, its analgesia is of short duration.
Ultra-low-dose (pg–gg/kg) of naloxone combined with opi-
oid agonists can improve their analgesic efﬁcacy [15] via block-
ing the excitatory opioid receptor pathway and enhancing
opioid analgesia [3,16,17] but not used before with fentanyl
as adjuvants to the local anesthetic in peribulbar anesthesia.
So, the aim of the present study was to evaluate the effect of
addition of ultra-low-dose of naloxone to fentanyl and lido-
caine for peribulbar anesthesia on the quality of the block
and the duration of postoperative analgesia.Table 1 Patient characteristics and duration of surgery in the
studied groups.
Group I
(n= 30)
Group II
(n= 30)
P value
Age (years) 57.8 ± 5.72 59.30 ± 4.81 0.276
Sex (male:female) 16:14 15:15
Weight (kg) 74.27 ± 6.88 72.20 ± 6.21 0.227
Duration of surgery (min) 51.93 ± 3.81 53.80 ± 3.89 0.065
Data expressed as mean ± SD.2. Patients and methods
After obtaining an institutional board approval and written
informed consent from the patient or his closest relative 60
adult patients of both sexes, ASA I and II scheduled for open
globe cataract surgery in the Ophthalmology Department
Tanta University Hospital were included in this randomized
double blind prospective clinical trial.
Exclusion criteria included clotting abnormalities and
patients on anticoagulant therapy, impaired mental status,
patients with communication difﬁculties, uncontrolled move-
ments or tremors e.g. Parkinsonism, inability to lie ﬂat, one
eyed patients, uncontrolled glaucoma, recent surgical proce-
dure on the same eye, high myopia, with axial length
P26 mm as detected by ultrasonography, and allergy to hyal-
uronidase or local anesthetics.
The trial is registered in the Australian New Zealand Clin-
ical Trials Registry: ACTRN12614000545662.
The primary end point was the duration of analgesia as
indicated by the ﬁrst time for rescue analgesic (measured from
the time of onset to the ﬁrst time of feeling of moderate or
severe pain). For each group 26 patients were required for nal-
oxone to increase the mean value of the ﬁrst time for rescue
analgesic by 20% [30 min (0.5 h)] based on a previous pilot
study in our institute with 90% power (a= 0.05%) and stan-
dard deviation (SD) of 0.55. We used 30 patients in each group
for more accurate statistical analysis. The patients were ran-
domized using a computer generated random numbers and
closed envelops into 2 groups (30 patients each) to undergo
peribulbar anesthesia. Group I (fentanyl group): each patient
received 50 lg fentanyl and lidocaine 2% with hyaluronidase
15 IU/ml. Group II (fentanyl-naloxone group): each patient
received 100 gg naloxone, 50 lg fentanyl and lidocaine 2%
with hyaluronidase 15 IU/ml.
Preoperatively, no premedication was given and, intrave-
nous cannula was inserted. The patients were monitored con-tinuously for ECG, heart rate, pulse oximetry. Arterial blood
pressure (ABP) was measured non-invasively every 5 min.
Topical local anesthetic (benoxinate hydrochloride) was
applied to the eye then, with the eye in the primary gaze posi-
tion, a 25-gauge short bevel needle was inserted trans-conjunc-
tivally at the junction between the medial two thirds and
lateral third of the inferior orbital rim in a strictly posterior
direction. Depth of needle insertion was limited to 25 mm.
The anesthetic mixture was injected after aspiration test and,
the injection was continued until subconjunctival edema and
lid fullness appeared. Intermittent digital compression was
applied to lower the intraocular pressure until sufﬁcient motor
block occurred.
Akinesia (immobility) of the globe and eye lids was scored
every 2 min till the best akinesia score. We used an 18-point
scale, which was the sum of six sub-scores for the four rectus
muscles, levator palpebrae and orbicularis oculi from 0 to 3
(0 = no block, 1 = partial akinesia not sufﬁcient for surgery,
2 = partial akinesia sufﬁcient for surgery, 3 = complete aki-
nesia) [18].
The best akinesia score: was the highest akinesia score
obtained for each block without or before supplemental injec-
tion. The total volume of local anesthetic injected, number of
patients who needed supplemental injection, time of onset,
time of ﬁrst request for rescue analgesic (time from the onset
of block to ﬁrst time of moderate or severe pain) and, occur-
rence of any complication (e.g. pain on injection, chemosis,
diplopia, bradycardia, hypotension, nausea, vomiting, etc)
were recorded. If after 10 min akinesia was insufﬁcient 4 ml
of the same solution was re-injected.
Pain was assessed during and after surgery at 30, 60,
90 min, 2, 3, 4, 6 and 8 h postoperatively, using Visual Ana-
logue Score (VAS). 0 = no pain, to 10 = maximum pain, 1–
3 = mild pain, 4–6 = moderate pain, >6 = severe pain.
Patients with moderate or severe pain received diclofenac
sodium 75 mg intramuscular injection. The intraocular pres-
sure (mmHg) was measured before, 2 and 10 min after injec-
tion of local anesthetic mixture.
The data were analyzed using SPSS (version 20), quantita-
tive data were expressed as mean ± SD (for age, weight, dura-
tion of surgery, onset, IOP, total akinesia score, best akinesia
score, total injected volume and ﬁrst time for rescue analgesic)
and analyzed using independent-t-test for comparison between
the two groups. F test was used for comparison of IOP within
the same group and Tukey’s test is used as post hoc test. The
VAS (did not follow the normal distribution was expressed as
median (range) and Mann–Whitney U test was used for com-
parison between the two groups. While, the sex, number of
patients who needed supplemental injection, and complica-
Table 2 Quality of block in the studied groups.
Group Group I (n= 30) Group II (n= 30) P value
Total injected volume (ml) 8.47 ± 1.33 9.00 ± 1.95 0.221
Onset (min) 8.40 ± 2.84 8.13 ± 2.47 0.699
Best akinesia score 15.83 ± 3.04 16.67 ± 2.60 0.259
Patients needed supplemental injection (n%) 5 (16.6%) 4 (13.3%)
Time to ﬁrst rescue analgesic (h) 4.30 ± 0.47 7.73 ± 0.98* <0.001
Data expressed as mean ± standard deviation (SD).
* Signiﬁcant at P< 0.05.
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statistically signiﬁcant.
3. Results
The two groups were comparable for the patient characteris-
tics; age, sex, weight, and duration of surgery (p> 0.05)
Table 1. As regards the quality of block; there was no signiﬁ-
cant difference between the two groups regarding the total
injected volume (ml) (p= 0.221), onset (minutes)
(p= 0.699), best akinesia score (p= 0.259), and number of
patients needed supplemental injection (n%). No patient expe-
rienced pain during surgery. The time to ﬁrst rescue analgesic
(hours) was signiﬁcantly longer in group II (7.73 ± 0.98) than
group I (4.30 ± 0.47) (P< 0.001); Table 2. No signiﬁcant dif-
ference was found between the two groups regarding the total
akinesia score at 2, 4, 6, 8 and 10 min postinjection (the p value
was 0.102, 0.515, 0.468, 0.455 and 0.259, respectively) Table 3.
The IOP was increased signiﬁcantly at 2 min postinjection
compared to the preinjection values in both groups. While,
there was a signiﬁcant decrease in the IOP 10 min compared
to 2 min postinjection in the two groups Table 4. The VAS
was signiﬁcantly lower at 60, 90 min, 2 and 3 h, then increased
signiﬁcantly at 6 h postoperatively in group II compared to
group I (P= 0.003, 0.002, <0.001, <0.001 and <0.001,Table 3 Total akinesia score in the studied groups.
Group I
(n= 30)
Group II
(n= 30)
P value
Total akinesia at 2 min 4.13 ± 0.94 4.60 ± 1.22 0.102
Total akinesia at 4 min 8.80 ± 2.17 9.17 ± 2.17 0.515
Total akinesia at 6 min 13.73 ± 3.03 13.17 ± 2.98 0.468
Total akinesia at 8 min 15.70 ± 3.16 16.30 ± 3.01 0.455
Total akinesia at 10 min 15.83 ± 3.04 16.67 ± 2.60 0.259
Data expressed as mean ± standard deviation (SD).
Table 4 Intraocular pressure in the studied groups.
Pre-injection 2 min post
Group I (n= 30) 10.40 ± 1.40 15.77 ± 1.
Group II (n= 30) 10.87 ± 1.38 15.20 ± 1.
P value 0.27 0.07
Data expressed as mean ± standard deviation (SD).
* Signiﬁcant difference between pre-injection and 2 min post-injection w
 Signiﬁcant difference between 2 and 10 min post-injection within therespectively; Fig. 1. As regards the complications; 1 patient
(3.33%) in group I, and 2 patients (6.67%) in group II had che-
mosis, while 3 patients (10%) in group I, and 2 (6.67%)
patients in group II had pain on injection. No diplopia,
post-operative squint, globe perforation, or penetration
occurred in any patient of the studied groups.
4. Discussion
In the present study there was a signiﬁcant prolongation of the
time to ﬁrst request for analgesic in the naloxone group. This
can be explained by the study of Crain and Shen, who demon-
strated that naloxone (NLX) and naltroxone (NTX) have
selective antagonistic effects on the excitatory opioid receptor
functions in nociceptive dorsal root ganglion (DRG), thus
unmasking the inhibitory effects of morphine and other opi-
oids acting on l, d and j receptors and provided a cellular
mechanism for such effect, as they elicited prolongation of
the Ca2+ dependent component of the action potential by
ultra-low-dose naloxone and naltroxone [19]. Naloxone pre-
vents the transient switch in G-protein coupling by l-opioid
receptor from Gi/o to Gs and attenuates the opioid tolerance
and dependence via high-afﬁnity interaction of naloxone to a
penta-peptide region in c-terminal ﬁlamin A (FLNA) interact-
ing with l-opioid receptors [20].
This is in agreement with the study of Movafegh et al. [3]
who studied the effect of addition of ultra-low-dose of nalox-
one to lidocaine 1.5% with or without fentanyl in axillary bra-
chial plexus block and they found that the ultra-low-dose of
naloxone prolongs the time to ﬁrst post-operative pain. Also,
Hamann and Sloan [9] in their case report used low dose
(20 gg) intrathecal naloxone added to intrathecal morphine
(2 mg) bolus and infusion of 5 mg morphine and 50 gg nalox-
one intrathecal daily throughout 3 years follow up period in a
patient with severe chronic low back pain (post-lamenectomy),
they reported that; the patient maintained pain reduction of
60–80% with a return to daily activities and no further
hospitalization.-injection 10 min post-injection P value
10* 11.23 ± 1.25 <0.001
03* 11.57 ± 1.17 <0.001
0.29
ithin the same group.
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Figure 1 Pain intensity in the studied groups.
164 H.A.A. Ezz, R.S. ElkalaAs regards the onset time and the akinesia score in the pres-
ent study, there was no signiﬁcant difference between the two
studied groups. In contrary to our results is the study of Mov-
afegh et al. [3] who found prolongation of the onset time in the
naloxone group. This difference may be due to the addition of
hyaluronidase to the local anesthetic in our study, which was
proved to decrease the onset time and improve the akinesia [21].
Concerning the IOP in the present study; in each group
there was a signiﬁcant increase in the IOP 2 min after injection
of the local anesthetic then, it became insigniﬁcant after 10 min
compared to the preinjection value while there was a signiﬁ-
cant decrease in the IOP 10 min compared to 2 min post-injec-
tion. This indicates that, the intermittent digital compression
was effective in reversing the increase in IOP after local anes-
thetic injection. The transient increase in IOP was due to injec-
tion of local anesthetic in the limited orbital space, and then it
decreased due to decrease of the external pressure on the globe
as a result of relaxation of the extra-ocular muscles [22]. In
agreement with our results is the study of Bowman et al. [21].
In the present study, there were few complications and
adverse effects which were chemosis and pain on injection with
no signiﬁcant difference between the two groups.
We conclude that, addition of ultra-low-dose naloxone to
fentanyl and lidocaine for peribulbar anesthesia prolongs the
duration of post-operative analgesia and decreases the analge-
sic requirement without increasing the adverse effects.Funding
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